Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 211-220

  Krapfenbauer, K ^b   Yoo, B Chul ^b   Cairns, N ^b   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ELECTRON TRANSPORT; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; ADULT; BIOSYNTHESIS; DNA SEQUENCE; ENZYMOLOGY; GENETICS; MITOCHONDRION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

ADULT; BASE SEQUENCE; CEREBELLUM; DOWN SYNDROME; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; NADH DEHYDROGENASE; NADH, NADPH OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0032585825     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6380-1_13     Document Type: Article

References (26)

1. Arnason U, Xu X, Gullberg A (1996) Comparison between the complete DNA sequences of homo and the common chimpanzee based on non-chimeric sequences. J Mol Evol 42: 145-152
2. Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16: 661-674
3. Burger PC, Vogel FS (1973) The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 73: 457-476
4. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
5. Casserino DS, Bennett JP (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear Responses and cell death in neurodegeneration. Brain Res Rev 29: 1-25
6. Chen H, Morris MA, Rossier C, Blouin JL, Antonarakis SE (1995) Cloning of the cDNA for the human ATP synthase OSCP subunit (ATP50) by exon trapping and mapping to chromosome 21q22.1-q22.2. Genomics 28: 470-476
7. De Coo RFM, Buddiger P, Smeets HJM, van Oost BA (1997) Molecular cloning and characterization of the human mitochondrial NADH:oxidoreductase 10kDa gene (NDUFV3). Genomics 45: 434-437
8. Epstein CJ (1992) Down Syndrome (Trisomy 21) In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw Hill, New York, pp 749-794
9. Gabuzda D, Busciglio J, Chen LB, Matsudiara P, Yankner B (1994) Inhibition of energy metabolism alters the processing of the amyloid precursor protein and indeuces a potentialoly amyloidogenic derivative. J Biol Chem 269: 13623-13628
10. Greber-Platzer S, Schatzmann-Turhani D, Wollenek G, Lubec G (1999) Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets2, encoded on chromosome 21 is not overexpressed in hearts of patienjts with Down Syndrome. Biochem Biophys Res Commun 254: 395-399
11. Hardmeier R, Hoeger H, Khoshsorur A, Lubec G (1997) Transcription and activity of superoxide dismutase, catalase and glutathione peroxidase following irradiation in radiation resistant and radiation sensitive mice. Proc Natl Acad Sci USA 94: 7572-7576
12. Hayn M, Kremser K, Singewald N, Nemethova M, Lubec G (1996) Evidence against the involvement of active oxygen species in the pathogenesis of Down Syndrome and Alzheimer Disease. Life Sci 59: 537-544
13. Kitzmueller E, Labudova O, Cairns N, Lubec G (1999) Differences in gene expression in fetal Down Syndrome brain. J Neural Transm (this volume)
14. Labudova O, Krapfenbauer K, Moenkemann H, Rink H, Kitzmüller E, Cairns N, Lubec G (1998) Decreased transcription factor junD in brains of patients with Down Syndrome. Neurosci Lett 252: 159-162
15. Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G (1999) Gene expression in fetal Down Syndrome brain as revealed by subtractive hybridization. J Neural Transm (this volume)
16. Labudova O, Kitzmüller E, Rink H, Cairns N, Lubec G (1999) Increased phosphoglycerate kinase in brains of patients with Down's syndrome but not with Alzheimer's disease. Clin Sci 96: 279-285
17. Markesberry WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147
18. Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
19. Parker WD, Parks JK, Filley CM, Kleinschmidt-DeMasters (1994) Electron transport defects in Alzheimer's disease braqin. Neurology 44: 1090-1096
20. Prince J, Jia S, Bave U, Anneren G, Oreland L (1994) Mitochondrial enzyme deficiencies in Down's syndrome. J Neural Transm [PD-Sect] 8: 171-181
21. Seidl R, Schuller E, Cairns N, Lubec G (1997) Evidence against increased glycoxidation in Alzheimer's disease. Neurosci Lett 232: 49-52
22. Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DANN-damage in Down Syndrome. Neurosci Lett 235: 137-140
23. Smith TS, Bennett Jr JP (1997) Mitochondrial toxins in neurodegenerative diseases. I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res 765: 183-186
24. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett Jr JP, Davis RE, Parker Jr WD (1997) Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49: 918-925
25. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraten P, Van Rooijen LAA, Derks HJMG, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38: 359-364
26. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17: 278-282